We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cephalon Signs Option Agreement to Acquire Ception Therapeutics

News   Jan 14, 2009

 
Cephalon Signs Option Agreement to Acquire Ception Therapeutics
 
 
 

RELATED ARTICLES

New Class of Drugs Could Treat Ovarian Cancer

News

A team of researchers across The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.

READ MORE

Novel Method Detects Cancerous DNA

News

A new method of determining the sequence of molecules in DNA can be used to detect small fragments of cancerous genetic material in blood samples from lung cancer patients with a high degree of accuracy.

READ MORE

FDA Approves First Treatment for Postpartum Depression

News

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE